TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancer
Stefano La Rosa(University of Insubria), Fausto Sessa(University of Insubria), Daniela Furlan(University of Insubria), Alessandro Vanoli(University of Pavia), Volkan Adsay(Koç University), Francesca Molinari(IRCCS Ospedale San Raffaele), Nora Sahnane(University of Insubria), Milo Frattini(Ente Ospedaliero Cantonale), Kenji Notohara(Kurashiki Central Hospital), Barbara Bernasconi(Ospedale di Circolo e Fondazione Macchi), Selenia Casnedi(Hôpital d'Hautepierre), Lizhi Zhang(Dalian Maritime University), Carlo Capella(University of Insubria), Marie-Pierre Chenard(Hôpital d'Hautepierre), Luca Albarello(University of Insubria), Maria Grazia Tibiletti(University of Insubria), Sofia Asioli(University of Turin)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
November 19, 2015
Cited by 27
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
|Annals of Surgery|2008|461
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
|The Journal of Immunology|2009|383
Diagnosis of IgG4-Related Tubulointerstitial Nephritis
|Journal of the American Society of Nephrology|2011|374